FGFR2 and esophageal squamous cell carcinoma: Furthermore, miR-671-5p targeting the FGFR2 3′-UTR was used to reduce the expression of FGFR2, which suppressed the proliferation, migration, invasion, and xenograft growth of ESCC cells.